Norwest Venture Partners is a 65-year-old firm backed solely by Wells Fargo. The firm has raised its 17th fund at $3 billion, maintaining its fund size despite the market downturn. Norwest Venture Partners invests in North America, India, and Israel, with a focus on early-stage and growth equity businesses. The firm has recently added a biotech team to its existing healthcare practice, allowing it to adjust its strategy based on market changes.